Skip to menu Skip to content Skip to footer

Inflammasome inhibitors as new first-in-class anti-inflammatory therapies (2022-2026)

Experts

Professor Kate Schroder

Affiliate of The Centre for Cell Biology of Chronic Disease
Centre for Cell Biology of Chronic Disease
Institute for Molecular Bioscience
NHMRC Leadership Fellow - Group Leader
Institute for Molecular Bioscience
Kate Schroder
Kate Schroder